Signals Blog
Menu

Michael Rudnicki

Posts by: Michael


Ethical and legal questions important in moving stem cell therapies to clinic

iPS cells give us an unprecedented opportunity to create patient- and disease-specific cells. Labs around the world have demonstrated that iPS cells can generate disease-specific cells for illnesses such as muscular dystrophy, Parkinson’s and type 1 diabetes, among many others. Generating these specific cell cultures is greatly advancing stem cell research by allowing researchers to […]

New Canadian-Californian investment in stem cell research aims to improve cancer treatments

I am excited to learn of today’s announcement that two large-scale projects to tackle stem cell therapies for cancer are to be funded by the California Institute for Regenerative Medicine (CIRM) and the Cancer Stem Cell Consortium (CSCC). This is most welcome news, not only because it demonstrates a continued investment in stem cell science […]

Nobel nominees were the founders of stem cell science

Speculation abounded earlier this week that the founders of stem cell science – James Till and Ernest McCulloch – would be honoured for their achievement with a prestigious Nobel Prize. While it turned out that the Prize was awarded to a deserving trio of researchers for their work on chromosomes, the buzz of anticipation and conjecture […]

Canadian stem cell researchers Eaves and Dick to receive hematology awards

The American Society of Hematology recently announced six award recipients to be honoured for their outstanding scientific contributions in the field of hematology. Among the distinguished scientists who are to receive awards are two Canadians – Connie Eaves and John Dick – both of whom are Stem Cell Network researchers. I am very proud of […]